A study in humans with coronary artery disease identified the miR-6764-5p as a biomarker for recurrent myocardial infarction risk, where it was upregulated in whole blood samples from patients with recurrent events compared to those without, with this differential expression remaining significant after false discovery rate correction (FDR <0.1) [Onuoha et al. DOI:10.1111/cts.13307].